{"database":"MetabolomicsWorkbench","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["http://www.metabolomicsworkbench.org/rest/study/study_id/ST001090/mwtab"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Metabolomics"],"technology_type":["NMR"],"disease":["Cancer"],"species":["Homo Sapiens"],"full_dataset_link":["http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001090"],"study_factor":["Treatment:No | Sensitivity:Sensitive","Treatment:Yes | Sensitivity:Sensitive","Treatment:No | Sensitivity:Resistant","Treatment:Yes | Sensitivity:Resistant"],"tissue":["Cultured Cells"],"submitter_affiliation":["University of Nebraska-Lincoln"],"sample_protocol":["NMR data."],"repository":["MetabolomicsWorkbench"],"data_protocol":[""],"name_synonyms":["2'-Deoxy-2'-Difluorocytidine, (beta-D-threo-pentafuranosyl)-Isomer, 2'-DFDC, insensitive, Malignant Neoplasm, LY, 2'-Difluorodeoxycytidine, Neoplasms, Benign Neoplasm, Metabonomic, Metabonomics, Tumor, Malignant, LY 188011, LY-188011, dFdCyd, Gemcitabine Hydrochloride, MT, Benign, 2'-Deoxy-2', Hydrochloride, Neoplasm, 2'-Difluoro-2'-Deoxycytidine, 2' Deoxy 2' Difluorocytidine, Cell., 2', Metabolomic, study, Gemcitabine, primary cancer, resistant, Malignancy, Benign Neoplasms, (D-threo-pentafuranosyl)-Isomer, Cancers, 2' Deoxy 2', malignant tumor, Malignant Neoplasms, Neoplasias, Gemicitabine, malignant neoplasm, (alpha-D-threo-pentofuranosyl)-Isomer, 2'' Difluorocytidine 5' O Monophosphate, 188011, Malignancies, Gemzar, 2''-Difluorocytidine-5'-O-Monophosphate, Neoplasia, Cancer, Tumors"],"additional_accession":[]},"is_claimable":false,"name":"NMR metabolomics study of Gemcitabine resistant cancer cells","description":null,"dates":{"publication":""},"accession":"ST001090","cross_references":{"TAXONOMY":["9606"]}}